Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

The Advertising Standards Authority (ASA) said ads – one featuring reality TV personality Gemma Collins – could not ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Adverts for prescription -only weight-loss jabs have been banned by a watchdog. The Advertising Standards Authority (ASA) ruled against the ads, making it “crystal clear” that all injectable forms of ...

The Advertising Standards Authority (ASA) has banned nine rulings against ads for weight-loss jabs, including one featuring ...

EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...

GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs completely ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

Dr Willie told Reach: “You should speak to your doctor about any conditions or medications before taking any weight loss injection. Mounjaro weight loss injections can lower your blood sugar levels ...

Currently, most GLP-1s are injections used to treat Type 2 diabetes. A few, including Wegovy, Zepbound, and Saxenda (liraglutide), are FDA-approved for weight loss.